Detalhe da pesquisa
1.
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Ann Oncol
; 35(1): 66-76, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866811
2.
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.
Ann Oncol
; 32(7): 881-895, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894335
3.
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial.
Ann Oncol
; 30(2): 281-289, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657853
4.
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer.
Ann Oncol
; 30(8): 1311-1320, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086949
5.
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial.
Ann Oncol
; 28(4): 874-881, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28168303
6.
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab.
Ann Oncol
; 28(12): 2932-2942, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950290
7.
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.
Ann Oncol
; 27(9): 1712-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287210
8.
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
Ann Oncol
; 27(7): 1291-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27117531
9.
Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results.
ESMO Open
; 8(4): 101580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390764
10.
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Ann Oncol
; 23(11): 2834-2842, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22700995
11.
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis.
Cancer Treat Res Commun
; 27: 100378, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905962
12.
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.
Eur J Cancer
; 51(16): 2321-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26283035